Eliana Merle
Stock Analyst at Barclays
(0.88)
# 4,028
Out of 5,051 analysts
431
Total ratings
36.6%
Success rate
-1.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Eliana Merle
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RGNX REGENXBIO | Maintained: Hold | $12 | $7.77 | +54.44% | 7 | Oct 13, 2026 | |
| MBX MBX Biosciences | Maintained: Buy | $88 | $52.02 | +69.17% | 7 | Oct 13, 2026 | |
| ALNY Alnylam Pharmaceuticals | Maintained: Buy | $450 | $227.02 | +98.22% | 18 | Oct 13, 2026 | |
| FDMT 4D Molecular Therapeutics | Maintained: Buy | $28 | $13.00 | +115.38% | 3 | Oct 13, 2026 | |
| BBIO BridgeBio Pharma | Reiterated: Buy | $157 → $156 | $65.75 | +137.26% | 23 | Oct 7, 2026 | |
| NTLA Intellia Therapeutics | Initiated Coverage: Sell | $8 | $12.58 | -36.41% | 1 | Oct 7, 2026 | |
| PTCT PTC Therapeutics | Reiterated: Buy | $122 | $62.92 | +93.90% | 15 | Oct 7, 2026 | |
| QURE uniQure | Downgraded: Hold | $60 → $28 | $21.84 | +28.21% | 15 | Oct 6, 2026 | |
| REGN Regeneron Pharmaceuticals | Reiterated: Buy | $917 | $762.81 | +20.21% | 6 | Oct 2, 2026 | |
| ASND Ascendis Pharma | Reiterated: Buy | $329 | $227.00 | +44.93% | 15 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $237 → $207 | $98.56 | +110.02% | 9 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $962 | $467.16 | +105.93% | 16 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $59 | $19.60 | +201.02% | 10 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $617 | $507.00 | +21.70% | 17 | Sep 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 | $43.67 | +94.64% | 25 | Sep 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $35 | $15.30 | +128.76% | 8 | Sep 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $8 → $18 | $8.80 | +104.55% | 5 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $48 → $125 | $213.74 | -41.52% | 32 | Aug 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $105 → $111 | $55.39 | +100.40% | 42 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $2.56 | +681.25% | 8 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $2.83 | +359.36% | 2 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $17.44 | +14.68% | 12 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $133 → $139 | $112.08 | +24.02% | 12 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $22 | $9.28 | +141.38% | 14 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $3.12 | +476.92% | 4 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $115 → $117 | $95.84 | +22.08% | 25 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $33 → $20 | $46.04 | n/a | 25 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $96 → $112 | $150.43 | n/a | 3 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $63 → $12 | $60.73 | n/a | 3 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.67 | n/a | 1 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $74 → $21 | $7.45 | n/a | 12 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $2.2 | $2.52 | n/a | 6 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $71 | $193.95 | n/a | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $5 | $99.26 | n/a | 3 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $10.52 | n/a | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $6.99 | n/a | 3 | Mar 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $192 → $134 | $29.57 | n/a | 10 | Aug 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $1.62 | n/a | 8 | Dec 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $3.38 | n/a | 4 | Mar 18, 2019 |
REGENXBIO
Oct 13, 2026
Maintained: Hold
Price Target: $12
Current: $7.77
Upside: +54.44%
MBX Biosciences
Oct 13, 2026
Maintained: Buy
Price Target: $88
Current: $52.02
Upside: +69.17%
Alnylam Pharmaceuticals
Oct 13, 2026
Maintained: Buy
Price Target: $450
Current: $227.02
Upside: +98.22%
4D Molecular Therapeutics
Oct 13, 2026
Maintained: Buy
Price Target: $28
Current: $13.00
Upside: +115.38%
BridgeBio Pharma
Oct 7, 2026
Reiterated: Buy
Price Target: $157 → $156
Current: $65.75
Upside: +137.26%
Intellia Therapeutics
Oct 7, 2026
Initiated Coverage: Sell
Price Target: $8
Current: $12.58
Upside: -36.41%
PTC Therapeutics
Oct 7, 2026
Reiterated: Buy
Price Target: $122
Current: $62.92
Upside: +93.90%
uniQure
Oct 6, 2026
Downgraded: Hold
Price Target: $60 → $28
Current: $21.84
Upside: +28.21%
Regeneron Pharmaceuticals
Oct 2, 2026
Reiterated: Buy
Price Target: $917
Current: $762.81
Upside: +20.21%
Ascendis Pharma
Sep 30, 2026
Reiterated: Buy
Price Target: $329
Current: $227.00
Upside: +44.93%
Sep 30, 2026
Reiterated: Buy
Price Target: $237 → $207
Current: $98.56
Upside: +110.02%
Sep 30, 2026
Reiterated: Buy
Price Target: $962
Current: $467.16
Upside: +105.93%
Sep 30, 2026
Reiterated: Buy
Price Target: $59
Current: $19.60
Upside: +201.02%
Sep 23, 2026
Reiterated: Buy
Price Target: $617
Current: $507.00
Upside: +21.70%
Sep 18, 2026
Reiterated: Buy
Price Target: $85
Current: $43.67
Upside: +94.64%
Sep 18, 2026
Reiterated: Buy
Price Target: $32 → $35
Current: $15.30
Upside: +128.76%
Sep 9, 2026
Upgraded: Buy
Price Target: $8 → $18
Current: $8.80
Upside: +104.55%
Aug 24, 2026
Reiterated: Hold
Price Target: $48 → $125
Current: $213.74
Upside: -41.52%
Aug 17, 2026
Reiterated: Buy
Price Target: $105 → $111
Current: $55.39
Upside: +100.40%
Aug 13, 2026
Reiterated: Buy
Price Target: $20
Current: $2.56
Upside: +681.25%
Aug 7, 2026
Reiterated: Buy
Price Target: $13
Current: $2.83
Upside: +359.36%
Aug 7, 2026
Reiterated: Hold
Price Target: $20
Current: $17.44
Upside: +14.68%
Aug 6, 2026
Reiterated: Buy
Price Target: $133 → $139
Current: $112.08
Upside: +24.02%
Jul 28, 2026
Reiterated: Sell
Price Target: $22
Current: $9.28
Upside: +141.38%
Jun 4, 2026
Reiterated: Buy
Price Target: $18
Current: $3.12
Upside: +476.92%
Nov 6, 2025
Reiterated: Hold
Price Target: $115 → $117
Current: $95.84
Upside: +22.08%
Aug 12, 2025
Reiterated: Hold
Price Target: $33 → $20
Current: $46.04
Upside: n/a
Aug 8, 2025
Reiterated: Hold
Price Target: $96 → $112
Current: $150.43
Upside: n/a
Jul 21, 2025
Downgraded: Hold
Price Target: $63 → $12
Current: $60.73
Upside: n/a
Jul 15, 2025
Reiterated: Buy
Price Target: $8
Current: $1.67
Upside: n/a
May 15, 2025
Reiterated: Buy
Price Target: $74 → $21
Current: $7.45
Upside: n/a
Jan 28, 2025
Reiterated: Hold
Price Target: $5 → $2.2
Current: $2.52
Upside: n/a
Jan 8, 2025
Reiterated: Buy
Price Target: $71
Current: $193.95
Upside: n/a
Apr 4, 2024
Reiterated: Hold
Price Target: $3 → $5
Current: $99.26
Upside: n/a
Oct 13, 2022
Initiated Coverage: Buy
Price Target: $22
Current: $10.52
Upside: n/a
Mar 3, 2021
Reiterated: Buy
Price Target: $10
Current: $6.99
Upside: n/a
Aug 19, 2020
Reiterated: Hold
Price Target: $192 → $134
Current: $29.57
Upside: n/a
Dec 11, 2019
Reiterated: Buy
Price Target: $40
Current: $1.62
Upside: n/a
Mar 18, 2019
Reiterated: Buy
Price Target: $8
Current: $3.38
Upside: n/a